Several recent studies have detected AXIN1 gene sequence variations in subsets of ovarian endometrial adenocarcinomas and advanced prostate cancer, indicating new potentially relevant AXIN1 mutations [23, 36]. The gene discussed is AXIN1; the disease is prostate carcinoma.